Jade Biosciences (JBIO) Free Cash Flow Growth (5y) (2025 - 2026)

Jade Biosciences (JBIO) Free Cash Flow Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,042.03 Bn	67,041.74 Bn	-
2	Nanobiotix	1,908.00 Bn	1,907.94 Bn	-
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-
4	BeOne Medicines	472.89 Bn	468.10 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.12 Bn	114.87 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.04 Bn	61.29 Bn	3.31 Bn
7	Belite Bio	62.68 Bn	62.68 Bn	-
8	Argenx Se	55.90 Bn	50.72 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.47 Bn	34.46 Bn	959.66 Mn
10	Jade Biosciences	1.17 Bn	863.31 Mn	-

Download Data